Canopy Growth Corp. Investors Learn the Hard Way That Profits Matter

Canopy Growth Corp. (TSX:WEED) announced earnings on June 27. WEED is down 3.8% since then on top of big losses leading up to its fourth-quarter report. Profits matter. Here’s why.

| More on:

Canopy Growth Corp. (TSX:WEED) announced on June 27 that its operations lost $15.2 million on $39.9 million in revenues. The reaction from investors since then has been rather muted, although its stock is down almost 4%.

While the top line is rocketing higher, unfortunately, so too is the bottom line. Losses, along with other business-specific and industry-related issues, have its stock in a funk not seen for a very long time.

It’s been almost three months since I last wrote about Canada’s largest medical marijuana company. Lots has happened to Canopy and the rest of the industry in a few short months, and while I generally see WEED in a positive light, I think investors need to remember why they buy stocks in the first place.

To make money!

Anyone who bought Canopy stock in the euphoria last November or this year in early February and is still holding is sitting on a 40% paper loss with not much hope for recovery in the second half of 2017.

Of course, when you’d bought its stock, I’m sure you weighed the risks against the rewards associated with owning a money-losing operation in a very young industry with a lot of potential regulatory roadblocks ahead.

You did, right? Oh, you didn’t? My condolences.

Earnings count 90% of the time

Almost every publicly traded stock, no matter how great the business behind it is, must answer the earnings bell at some point in its young history.

Sure, there are outliers, like Amazon.com, Inc., Netflix, Inc., and Shopify Inc. here in Canada. They’re given considerable leeway while they scale their businesses to the appropriate moment when volume more than makes up for low prices.

However, these are unusually rare circumstances where a business changes how we live our lives, whether it be personally or professionally.

Unless Canopy fits the Amazon mould and is somehow uniquely changing our lives, which, at the moment, isn’t something we can easily determine so early in the game, earnings become the default financial indicator that all investors must rely on to skate through an unknown future.

How long do we have to wait?

That’s the $20 million question. If I had the answer, I doubt I would be sitting here typing away at my computer. I’d be out on a lake somewhere enjoying the summer, but I digress.

Fool.ca contributor David Jagielski recently recommended investors consider MedReleaf Corp. (TSX:LEAF), a Toronto-based cannabis producer, because it is grown organically without the need for acquisitions. It’s one of the only profitable cannabis producers anywhere, and its stock is up 10% since a poor first-day return when it went public in June.

He’s right. Profits matter.

Since inception, MedReleaf’s objective has been the creation of long-term shareholder value, a trait shared by all great companies, regardless of industry,” wrote Neil Closner, MedReleaf’s CEO in the company’s annual message. “It is a laser-like focus on this key objective that has driven every strategic and operational decision that management has made and that we will continue to make as we work to extend our leadership position within the cannabis industry.”

MedReleaf’s financials show that as its production facility in Markham, Ontario, got to 100% capacity in the fourth quarter of 2016, its cash cost per gram sold dropped by 46% in fiscal 2017. Also, its adjusted product contribution per gram sold increased by 19% — a telltale sign of a good business operation.

Bottom line

I still think Canopy has an opportunity to be the world’s largest cannabis company, but that’s going to mean as long as 36 months without profits.

My suggestion is to buy some MedReleaf stock to go with your Canopy shares. That way, you lower your risk profile while staying in the game.

After all, profits matter.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned. David Gardner owns shares of Amazon and Netflix. Tom Gardner owns shares of Netflix and Shopify. The Motley Fool owns shares of Amazon, Netflix, Shopify, and SHOPIFY INC. Shopify is a recommendation of Stock Advisor Canada.

More on Investing

young woman celebrating a victory while working with mobile phone in the office
Dividend Stocks

3 CRA Benefits Most Canadians Can Grab in 2024

You can save on taxes by claiming the dividend tax credit on Fortis Inc (TSX:FTS) shares.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »